Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
The pheochromocytomas are an important cause of secondary hypertension. Although pheochromocytoma susceptibility may be associated with germline mutations in the tumor-suppressor genes VHL and NF1 and in the proto-oncogene RET, the genetic basis for most cases of nonsyndromic familial pheochromocytoma is unknown. Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations. Germline SDHD mutations were originally described in hereditary paraganglioma, a dominantly inherited disorder characterized by vascular tumors in the head and the neck, most frequently at the carotid bifurcation. The gene products of two components of succinate dehydrogenase, SDHC and SDHD, anchor the gene products of two other components, SDHA and SDHB, which form the catalytic core, to the inner-mitochondrial membrane. Although mutations in SDHC and in SDHD may cause hereditary paraganglioma, germline SDHA mutations are associated with juvenile encephalopathy, and the phenotypic consequences of SDHB mutations have not been defined. To investigate the genetic causes of pheochromocytoma, we analyzed SDHB and SDHC, in familial and in sporadic cases. Inactivating SDHB mutations were detected in two of the five kindreds with familial pheochromocytoma, two of the three kindreds with pheochromocytoma and paraganglioma susceptibility, and 1 of the 24 cases of sporadic pheochromocytoma. These findings extend the link between mitochondrial dysfunction and tumorigenesis and suggest that germline SDHB mutations are an important cause of pheochromocytoma susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, a biallelic loss of succinate dehydrogenase (SDH), an alteration found in familial paragangliomas and pheochromocytomas, as well as in a subset of sporadic gastrointestinal stromal tumors, creates a build-up of succinate (Astuti et al., 2001; Janeway et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Astuti et al., 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The results of a clinical study further confirmed this observation by showing that patients with nonmetastatic lung cancer harbored loss-of-function mutations in SDH5128.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
Experimental — accuracy not yet measuredIn the citing paper
“In cancer cells, mutations in succinate dehydrogenase subunit B (SDHB) cause susceptibility to familial pheochromocytoma99 and familial paraganglioma100 as well as gastrointestinal stromal tumors101.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [99]
In the citing paper
“In addition to the tumorigenic effects of succinate accumulation, SDH5 mutation is the key driver supporting the acquisition of epithelial–mesenchymal transition (EMT) characteristics.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“…the iron-sulfur–protein subunit) and in both SDHC and SDHD (i.e., the genes for the integral membrane–protein subunits) are associated with neoplasia (Baysal et al. 2000; Niemann and Muller 2000; present study), autosomal recessive homozygous SDHA (i.e., the gene for the flavoprotein subunit)…”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundCockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050 · cited 1×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 4×
“…herein: PGL1 (MIM 168000), which results from SDHD mutations at 11q23; PGL2 (MIM 601650), which maps to 11q13, although the causative gene has not been identified (Mariman et al. 1995); and PGL3 (MIM 605373), which results from SDHC mutations at 1q21 (Baysal et al. 2000; Niemann and Muller 2000).”
BackgroundInfluentialBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 2×
“SDHA mutations are associated with juvenile encephalopathy (Bourgeron et al. 1995), and the phenotypic consequences of SDHB mutations have not been defined.”
BackgroundHoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382 · cited 1×
“Interestingly, germline VHL mutations that predispose patients to pheochromocytoma do not impair HIF-1a ubiquitylation (Clifford et al. 2001; Hoffman et al. 2001).”
BackgroundClifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Gimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Self-citation
Cited by
Items 901–999 of 999
Mitochondrial-to-Nuclear Communications in Cancer
Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_4 · Cited by 2
Genetic Alterations in Pheochromocytoma and Paraganglioma
Welander, J. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-114806 · Cited by 2
Ercolino, T., Taurino, C., Sestini, R., Bacca, A., Genuardi, M., Mannelli, M., & BERNINI, G. P. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345697 · Cited by 2
Neumann, H. P. H., & de Herder, W. W. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0340 · Cited by 3
“Within months, the SDH components B and C (together with SDHD umbrellaed under SDHx) were shown to predispose to similar tumors, if the res- pective genes (SDHB and SDHC) were mutated (Niemann & Müller 2000, Astuti et al. 2001).”
BackgroundEnergy Metabolism and Metabolic Targeting of Neuroblastoma
Aminzadeh-Gohari, S., Feichtinger, R. G., & Kofler, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812005-7.00007-2 · Cited by 8
Diethylnitrosamine (DEN) induced morphological and biomolecular changes in mouse liver mitochondria
Basaiawmoit, S. P., Alam, A., Sohkhlet, M., Jamir, R. P., & Dutta, S. P. (2016) · Cited by 2
Mitochondrial sirtuins at the crossroads of energy metabolism and oncogenic transformation
Grabacka, M., & Plonka, P. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00001-2 · Cited by 3
MOLECULAR AND CLINICAL CHARACTERISTICS OF TRICARBOXYLIC ACID CYCLE-ASSOCIATED TUMORS
Lehtonen, H. J. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 2
Genetic Susceptibility to Cancer
Spain, S. L., & Tomlinson, I. P. M. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap04.pub2 · Cited by 2
The Role Of Fumarase (FH) In Tumorigenesis
Lehtonen, R. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 2
Loss of SDHB reprograms energy metabolisms and inhibits high fat diet induced metabolic syndromesPreprint
Mu, C., Ma, B., Zhang, C., Geng, G., Zhang, X., Chen, L., Wang, M., Li, J., Zhao, T., Cheng, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/259226 · Cited by 3
“The genes encoding complex II subunits were found to be mutated in various types of tumor, such as paraganglioma (PGL) [7], pheochromocytoma (PHEO) [8], gastrointestinal stromal tumor (GIST) [9], renal cell carcinoma and Leigh syndrome [10].”
BackgroundPavlova, N. N., & Thompson, C. B. (2016) · Wiley eBooks · doi:10.1002/9781119000822.hfcm015 · Cited by 2
Young, A. L., & Young, W. F. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_20 · Cited by 2
The 3PAs syndrome and succinate dehydrogenase deficiency in pituitary tumors
Xekouki, P., Daraki, V. N., Betsi, G., Chrysoulaki, M., Sfakiotaki, M., Mytilinaiou, M. G., & Stratakis, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814537-1.00001-4 · Cited by 1
A Case for Genetic Testing in Isolated Tympanic Paragangliomas
Shrivastava, M. K., Curran, J. F., Sheerin, F., Mohammadi, B. J., Halliday, D. J., & MacKeith, S. A. C. (2022) · Otology & Neurotology · doi:10.1097/mao.0000000000003557 · Cited by 1
Li, Q., Ge, W., Zhang, Y., Xu, Q., Xu, J., Zhang, Y., Guo, X., Sheng, W., & Zhu, L. (2026) · Human Cell · doi:10.1007/s13577-025-01342-4 · Cited by 1
“3E) [26–31].”
Alzahrani, A. S., Alghamdi, B., Benito, A. D., & Mohamed, G. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag070 · Cited by 1
The Role of the Surgical Pathologist in the Recognition of Hereditary SDH-Deficient Tumor Syndromes
Juhlin, C. C., & Mete, Ö. (2026) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000541 · Cited by 2
Semenova, V., Zhukovskaya, E., Zelenova, E. E., Михайловна, К. В., Krasnov, G. S., Levashov, A., Sagoyan, G. B., Белышева, Т. С., Kharchikov, D., Suleymanova, A. M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146395 · Cited by 2
“Germline mutations of SDHx , including SDHB , result in loss of function and the development of various types of tumors, primarily pheochromocytoma and paraganglioma [64].”
MOLECULAR GENETICS OF SOFT TISSUE TUMORS
Lasota, J. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781049.006 · Cited by 1
Timmers, H. J. L. M., & Pacák, K. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.399 · Cited by 1
Expression of IDH1 Mutant Protein R132H and SDHB in Adult and Pediatric Gliomas
Ballester, L. Y., Aung, P. P., Lai, J., Nóbrega, R., Patrocínio, R. M. D. S. V., Wang, Z., Miettinen, M., Warren, K. E., & Qeuzado, M. (2014) · International Journal of Neuropathology · doi:10.7726/ijn.2014.1003 · Cited by 1
“SDHB is another enzyme in the Kreb's cycle that has been associated with tumor development, in particular in pheochromocytomas/paragangliomas and gastrointestinal stromal cell tumors (GIST) (Astuti et al., 2001; Gill et al., 2010).”
BackgroundHypertension in a teenager: a family affair
Dubb, S. S., Tafader, A., Meeran, K. M., & Fletcher, J. A. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-200221 · Cited by 1
Mitochondrial DNA variation in extremely selected traits: longevity and elite athletic performance
Niemi, A. (2005) · Cited by 2
Mitochondrial dysfunction in kidney diseases
Galvan, D. L., & Perico, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00005-x · Cited by 1
Malignant pheochromocytoma: pain, palpitation, perspiration and perplexities
Ananthakrishnan, N., Sanniyasi, S., & Ravikumar, D. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-239991 · Cited by 1
Allolio, B., Nies, C., Moll, R., Klose, K., Kann, P. H., Pfestroff, A., Waldmann, J., Bartsch, D. K., Lehnert, H., Dralle, H., et al. (2012) · Springer eBooks · doi:10.1007/978-3-642-14285-7_4 · Cited by 1
Hereditary Renal Cell Carcinoma
Dawsey, S. J., & Gupta, S. (2022) · Kidney Cancer · doi:10.3233/kca-210008 · Cited by 2
“The 4 genes that encode for mitochondrial SDH are SDHA at loci 5p15 [106], SDHB at loci 1p36 [107], SDHC at loci 1q21 [108], SDHD at 11q23 [104] and this syndrome is known to occur in all except SDHA.”
BackgroundWass, J. A. H., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0003 · Cited by 1
Exome sequencing and SDH (A, B) immunohistochemistry of canine Pheochromocytomas
Abed, F. M., & Dark, M. J. (2022) · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences · doi:10.33899/ijvs.2022.135825.2526 · Cited by 2
Mamedova, E., Lisina, D., & Belaya, Z. E. (2023) · Problems of Endocrinology · doi:10.14341/probl13196 · Cited by 1
Pheochromocytoma: A Troublesome Tumor
Patel, T., Singleton, L. A., Mejia, M., Senior, A., & Millis, R. M. (2023) · Cureus · doi:10.7759/cureus.45490 · Cited by 1
Paraaortic Extra-Adrenal Paraganglioma: Challenging Robotic Resection
Nikiforchin, A., Baron, E., Wernberg, J. A., & Sharma, R. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15267-z · Cited by 1
Carotid body tumors—epidemiology and surgical resection
Shiga, K., Katagiri, K., Ikeda, A., Saito, D., Oikawa, S., Tsuchida, K., Miyaguchi, J., Kusaka, T., & Tamura, A. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf074 · Cited by 1
Pheochromocytoma and paraganglioma – an overview
Łubińska, M., & Sworczak, K. (2014) · Oncoreview · Cited by 1
Mitochondrial Tumor Suppressors
Baysal, B. E. (2008) · Springer eBooks · doi:10.1007/978-0-387-84835-8_9 · Cited by 1
“The discovery of SDHD mutations led to identification of mutations in the other subunit genes SDHB on chromosome band 1p35 (PGL type 4, PGL4) ( Astuti et al. 2001 ) and SDHC on chromosome band 1q23 (PGL3) (Niemann and Muller 2000) in PGL families.”
BackgroundEndocrine metabolism III: adrenal glands
Ha, C. E., & Bhagavan, N. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88541-6.00001-6 · Cited by 1
Golden, T. R., Morten, K., Johnson, F., Samper, E., & Melov, S. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50008-x · Cited by 1
Update on diagnostic and therapeutic management of paraganglioma
Costa, H. E. L. D. L. F. F., & Ernesto, M. (2014) · Revista cubana de endocrinología · Cited by 1
Patócs, A., Likó, I., Butz, H., Baghy, K., & Rácz, K. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30316 · Cited by 4
“A klinikai gyakorlatban phaeochromocytoma, illetve paraganglioma esetén a leggyakrabban a RET, VHL, SDHB és SDHD gének vizsgálatát végzik [1, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], de indokolt esetben a többi gén vizsgálata is szükséges lehet.”
Whitworth, J., & Maher, E. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420196-5.00020-4 · Cited by 2
Self-citationGenetics of Pheochromocytoma and Paraganglioma
Babic, B., & Nilubol, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_5 · Cited by 1
Biomarker, Molecular, and Technologic Advances in Urologic Pathology, Oncology, and Imaging
Ellis, C. L., Harik, L. R., Cohen, C., & Osunkoya, A. O. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0263-sa · Cited by 1
Alzahrani, A. S., Alswailem, M. M., Albattal, S. B., Qasem, E., Murugan, A. K., & Al‐Hindi, H. (2019) · International Journal of Endocrine Oncology · doi:10.2217/ije-2018-0003 · Cited by 1
Co-existent Epicardial Paraganglioma and Anterior Mediastinal Thymoma
Dudgeon, M., Sonavane, S. K., Parent, E. E., Khoór, A., & Thomas, M. (2020) · Journal of Radiology Case Reports · doi:10.3941/jrcr.v14i10.4101 · Cited by 1
Waguespack, S. G., & Fishbein, L. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00015-4 · Cited by 11
Endoscopic Endonasal Approach to Rare Clival Paraganglioma: Case Report and Review of Literature
Okasha, M., Abougamil, A. B., Raslan, A., Roy, A., Bódi, I., Maratos, E. C., Thomas, N., & Barazi, S. A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01032-w · Cited by 1
Hodgson, S. V., Foulkes, W. D., Eng, C., & Maher, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2375-0_4 · Cited by 1
Self-citationPheochromocytomas in Complex Genetic Disorders
Opocher, G., Ferrara, A. M., Zovato, S., Barbon, G., Taschin, E., & Schiavi, F. (2021) · Endocrinology · doi:10.1007/978-3-319-89497-3_14 · Cited by 1
Ragab, E. M., Khamis, A. A., Gamal, D. M. E., & Mohamed, T. M. (2023) · Journal of Cellular Immunology · doi:10.33696/immunology.5.169
DEFECTS IN TRICARBOXYLIC ACID CYCLE ENZYMES FUMARATE HYDRATASE AND SUCCINATE DEHYDROGENASE IN CANCER
Ylisaukko‐oja, S. K. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 1
Pathogenesis of Pheochromocytoma
Isobe, K., Takekoshi, K., Kawakami, Y., & Nakai, T. (2003) · KARGER eBooks · doi:10.1159/000074655 · Cited by 1
Mobine, H. R. (2008) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Molecular basis of hereditary leiomyomatosis and renal cell cancer (HLRCC)
Kiuru, M. H. (2002) · Helda - University of Helsinki Institutional Repository · Cited by 1
The Pathogenesis of Pheochromocytomas: Of Mice and Men
Korpershoek, E. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Use of mutation analysis in endocrine neoplasia syndromes
Chew, S. L. (2009) · Clinical Medicine · doi:10.7861/clinmedicine.9-4-362 · Cited by 1
Mannelli, M., Parenti, G., Canu, L., Filpo, G. D., & Rapizzi, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65796-3 · Cited by 2
Cellular Adaptations to Oxidative Phosphorylation Defects in Cancer
Srivastava, S., & Moraes, C. T. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_5 · Cited by 1
“cell cancer [18], and mutations in the succinate dehydrogenase (SDH) subunits B, C, and D have been shown to be associated with hereditary paragangliomas and pheochromocytomas [19–21].”
BackgroundSíndromes de neoplasia endocrina múltiple
Callender, G. G., Rich, T. A., & Perrier, N. D. (2008) · Clínicas quirúrgicas de Norteamérica
Feochromocytom obou nadledvin se současnou extraadrenální lokalizací - kazuistika
Baker, K., Morávek, P., Čáp, J., Jaroslav, P., & Louda, M. (2004) · Česká urologie
Loureiro, V. C. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-22042007-204736
From chromaffin cells to Phaeochromocytoma: insight into the sympathoadrenal cell lineage
Cleary, S. (2007) · Murdoch University Research Portal
Hypoxia‐Induced Gene Regulation through Hypoxia Inducible Factor‐1α
Case, A. J., & Domann, F. E. (2009) · Wiley eBooks · doi:10.1002/9783527627585.ch9
Mutations de gènes impliqués dans le métabolisme énergétique et cancer
Thibault, C., & Gimenez‐Roqueplo, A. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2320-8
“SDH – SDHA – SDHB – SDHC – SDHD – SDHAF2 Succinate + ubiquinone → fumarate + ubiquinol Constitutionnelles Autosomique dominant PH/PGL héréditaire (21 %) et sporadique (8 %) [3,5,7] – Tête et cou – Thoracoabdominopelviens Mauvais pronostic pour SDHB”
BackgroundFurther delineation of molecular alterations in adreno-medullary tumors
Geli, J. (2007) · Figshare
Mitochondrial Complex II in Cancer
Kľučková, K., Neužil, J., & Rohlena, J. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_4
Kunkle, B. W. (2011) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi11120809
Mitochondria : a target for anticancer therapy
Kruspig, B. (2014) · Figshare
Miettinen, M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781049.027
Feokhromotsitoma: klinicheskie rekomendatsii I mezhdunarodnogo Simpoziuma (ISP)
Beltsevich, D. G. (2007) · Endocrine Surgery · doi:10.14341/2306-3513-2007-1-3-11
DNA methylation and gene expression patterns in adrenal medullary tumors
Kiss, N. B. (2009) · Figshare
Caractérisation génétique des atteintes hépatiques mitochondriales
Beinat, M. (2013) · theses.fr (ABES) · doi:10.70675/d8fe07c7z1083z474dzae3bzf3d89e2a866d · Cited by 1
Pediatric Paragangliomas: Role of Germline Mutation in Succinate Dehydrogenase
Prasad, P. K., & Yang, E. (2012) · Pediatric cancer · doi:10.1007/978-94-007-2957-5_30
Pheochromocytoma and Paraganglioma
Corssmit, E. P. M., & van Hulsteijn, L. T. (2015) · Springer eBooks · doi:10.1007/978-3-662-45215-8_24
Kao, S. C.-S., & Pinto-Rojas, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1729-7_12 · Cited by 2
Paragangliomas timpánicos y yugulares
Huy, P. T. B., & Duet, M. (2003) · EMC - Otorrinolaringología · doi:10.1016/s1632-3475(03)72002-5
The enzyme succinate dehydrogenase (SDH) and its role in hereditary pituitary adenomas
Панкратова, Ю. В., Przhiyalkovskaya, E. G., Pigarova, E. A., & Dzeranova, L. K. (2013) · Obesity and metabolism · doi:10.14341/omet2013410-15
Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma
Schmidt, L. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_11
Tobias, E. S., Yeap, P. M., Mavraki, E., Fletcher, A. J., Freel, M., Cooke, A., Bradshaw, N., Murday, V. A., Davidson, R., Perry, C. G., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3673
Lairmore, T. C. (2003) · Problems in General Surgery · doi:10.1097/00013452-200309000-00002
La génétique des paragangliomes
Burnichon, N., Abermil, N., Buffet, A., Favier, J., & Gimenez‐Roqueplo, A. (2012) · Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale · doi:10.1016/j.aforl.2012.07.425
A novelSDHDmutation associated with neck paraganglioma
Reboll, R., Martínez-León, J., Zapater, E., Juez, M., García-Planells, J., Martínez‐Cadenas, C., & Basterra, J. (2011) · Acta Oto-Laryngologica · doi:10.3109/00016489.2011.587201
“To date, three genes have been identified that are associated with familial PGL with significant genotype–phenotype correlations: succinate dehydrogenase subunit (SDH) D, SDHB, and SDHC.”
BackgroundOrloff, M. S., & Eng, C. (2009) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(09)79232-x
Self-citationOther Genetic Syndromes (TSC, VHL, NF1, etc.)
Garicochea, B. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-997-0_4
Farage, M., & Godoy‐Matos, A. F. (2012)
The pathophysiology of respiratory chain dysfunction
Silva, J. P. (2005) · Figshare
Epigenetic basis for the oncogenic potential of IDH mutations
Lü, C. (2013) · ScholarlyCommons (University of Pennsylvania)
Ghazi, A. A., Khah, A. M., Kamani, F., Zare, K., Sadeghipour, A., Hedayati, M., Yeganeh, M. Z., Cranston, T., & Grossman, A. B. (2014) · HORMONES · doi:10.14310/horm.2002.1500
Timmers, H. J. L. M., Gimenez‐Roqueplo, A., Mannelli, M., & Pacák, K. (2009)
Cancer of the Kidney and Urogenital Tract
Maher, E. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00070-7
Self-citationPreface to the column "Metabolism of Childhood Cancer".
Rakheja, D. (2015) · PubMed · doi:10.3978/j.issn.2224-4336.2015.02.02
“Mutations in nuclear genes encoding subunits of succinate dehydrogenase (SDH) have been found in pheochromocytomas and paragangliomas (17-19).”
BackgroundGenetic and molecular background of pheochromocytoma and paraganglioma
Stenman, A. (2015) · Figshare
FUMARATE HYDRATASE AND SUCCINATE DEHYDROGENASE IN NEOPLASIA
Vanharanta, S. (2006) · Helda - University of Helsinki Institutional Repository
A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody
Bader, A. G., Brown, D., Winkler, M., Shim, E., Livi, C. B., Rakheja, D., Tan, J. C., Benson, D. G., Parekh, V., Kho, E.-Y., et al. (2014)
Neumann, H. P. H., Michelsen, K. S., & Yu, R. (2014)
Metadata
- Authors
- Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R.
- Affiliations
- University of Birmingham (GB)
- Dana-Farber Cancer Institute (US)
- Royal Victoria Infirmary (GB)
- Queen Elizabeth Hospital (GB)
- Uppsala University (SE)
- University of Cambridge (GB)
- Corresponding author
- Maher, Eamonn R.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 69
- Issue
- 1
- Pages
- 49-54
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226047
- OpenAlex
- W2025719835
- Cited by
- 1,087
- References
- 28
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 18 · 2023: 31 · 2022: 29 · 2021: 40 · 2020: 29 · 2019: 51 · 2018: 42 · 2017: 47 · 2016: 54 · 2015: 46 · 2014: 70 · 2013: 61 · 2012: 75
- FWCI
- 37.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4401 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation
- National Cancer Institute (P-30-CA-16058, P30CA016058)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- succinate dehydrogenase, SDHB, SDHC, pheochromocytoma, paraganglioma, germline mutations, mitochondrial dysfunction, sporadic pheochromocytoma, tumor suppressor, RET proto-oncogene, VHL, neurofibromatosis type 1
- MeSH terms
- Proto-Oncogene Mas, Amino Acid Sequence, Base Sequence, DNA Mutational Analysis, Female, Haplotypes, Humans, Male, Molecular Sequence Data, Mutation, Paraganglioma, Pedigree, Pheochromocytoma, Succinate Dehydrogenase, Sequence Alignment, Germ-Line Mutation, Loss of Heterozygosity, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.